Additionally, polymorphisms in the fat mass and obesity-associated (FTO) gene, the so-called ‘obesity gene’, has been recognised to be involved in the progression of insulin resistance and presence of T2D in obese patients84, as well as responsiveness to dietary, exercise and drug-based weight loss interventions85. Here, FTO is linked to obesity due to melanocortin 4 receptor deficiency.